Suppr超能文献

相似文献

1
Predicting health utilities for children with autism spectrum disorders.
Autism Res. 2014 Dec;7(6):649-63. doi: 10.1002/aur.1409. Epub 2014 Sep 25.
4
Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire.
Qual Life Res. 2010 Feb;19(1):65-80. doi: 10.1007/s11136-009-9558-z. Epub 2009 Nov 26.
6
Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applications.
Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):485-503. doi: 10.1586/erp.12.29.
7
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.
J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):136-46. doi: 10.1016/j.jaac.2011.11.010. Epub 2011 Dec 23.
8
Cognitive Functions and Health Related Quality of Life of Institutional Autism Spectrum Disorder Children in Dhaka city.
Bangladesh Med Res Counc Bull. 2015 Dec;41(3):151-159. doi: 10.3329/bmrcb.v41i3.29973.

引用本文的文献

2
A systematic review of condition-specific preference-based measures used in young people and their valuation methods.
J Patient Rep Outcomes. 2024 Dec 19;8(1):151. doi: 10.1186/s41687-024-00826-5.
3
Predictors of health-related quality of life for children with neurodevelopmental conditions.
Sci Rep. 2024 Mar 16;14(1):6377. doi: 10.1038/s41598-024-56821-9.
4
Predictors of Health-Related Quality of Life in Neurodivergent Children: A Systematic Review.
Clin Child Fam Psychol Rev. 2024 Mar;27(1):91-129. doi: 10.1007/s10567-023-00462-3. Epub 2023 Dec 9.
5
The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder.
PLoS One. 2023 Apr 18;18(4):e0282906. doi: 10.1371/journal.pone.0282906. eCollection 2023.
6
Economic Evaluation of Early Interventions for Autistic Children: A Scoping Review.
J Autism Dev Disord. 2024 May;54(5):1691-1711. doi: 10.1007/s10803-023-05938-3. Epub 2023 Mar 13.
9
Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease.
Qual Life Res. 2022 Sep;31(9):2729-2738. doi: 10.1007/s11136-022-03167-2. Epub 2022 Jun 17.

本文引用的文献

2
Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
Pharmacoeconomics. 2014 Jul;32(7):693-706. doi: 10.1007/s40273-014-0153-y.
3
Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain?
J Natl Cancer Inst. 2013 Jun 5;105(11):766-73. doi: 10.1093/jnci/djt066. Epub 2013 Apr 11.
4
Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applications.
Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):485-503. doi: 10.1586/erp.12.29.
6
The ADOS calibrated severity score: relationship to phenotypic variables and stability over time.
Autism Res. 2012 Aug;5(4):267-76. doi: 10.1002/aur.1238. Epub 2012 May 24.
7
National Institutes of Health approaches to dissemination and implementation science: current and future directions.
Am J Public Health. 2012 Jul;102(7):1274-81. doi: 10.2105/AJPH.2012.300755. Epub 2012 May 17.
8
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities.
Genet Med. 2013;14(8):703-712. doi: 10.1038/gim.2012.24. Epub 2012 Apr 5.
10
Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.
Med Decis Making. 2012 Jul-Aug;32(4):554-68. doi: 10.1177/0272989X11427761. Epub 2011 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验